+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Akari Therapeutics Plc (AKTX) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company that develops treatments for rare and orphan autoimmune and inflammatory diseases. The company offers coversin drugs that acts on complement component-C5 that helps in preventing the release of C5a and formation of C5b - 9. The company’s pipeline products include paroxysmal nocturnal hemoglobinuria, guillain barre syndrome and atypical hemolytic uremic syndrome. Akari offers solutions in therapeutic areas of spanning hematology, nephrology, transplantation, neurology and ophthalmology. The company operates in Switzerland, Israel, the UK and the US. Akari is headquartered in New York, the US.

Akari Therapeutics Plc Key Recent Developments

Jan 23, 2018: Akari Therapeutics Strengthens Board with Two Senior Industry Appointments
Aug 21, 2017: Akari Therapeutics Announces Appointment of David Horn Solomon as CEO
May 30, 2017: Akari Therapeutics Announces Resignation of CEO
Jan 04, 2017: Akari Therapeutics Expands Clinical and Regulatory Teams with Industry Veterans

This comprehensive SWOT profile of Akari Therapeutics Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Akari Therapeutics Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Akari Therapeutics Plc - Key Information
  • Akari Therapeutics Plc - Overview
  • Akari Therapeutics Plc - Key Employees
  • Akari Therapeutics Plc - Key Employee Biographies
  • Akari Therapeutics Plc - Key Operational Heads
  • Akari Therapeutics Plc - Major Products and Services
  • Akari Therapeutics Plc - History
  • Akari Therapeutics Plc - Company Statement
  • Akari Therapeutics Plc - Locations And Subsidiaries
  • Akari Therapeutics Plc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Akari Therapeutics Plc - Business Description
  • Akari Therapeutics Plc - Corporate Strategy
  • Akari Therapeutics Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Akari Therapeutics Plc - Strengths
  • Akari Therapeutics Plc - Weaknesses
  • Akari Therapeutics Plc - Opportunities
  • Akari Therapeutics Plc - Threats
  • Akari Therapeutics Plc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Akari Therapeutics Plc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Akari Therapeutics Plc, Key Information
  • Akari Therapeutics Plc, Key Ratios
  • Akari Therapeutics Plc, Share Data
  • Akari Therapeutics Plc, Major Products and Services
  • Akari Therapeutics Plc, History
  • Akari Therapeutics Plc, Key Employees
  • Akari Therapeutics Plc, Key Employee Biographies
  • Akari Therapeutics Plc, Key Operational Heads
  • Akari Therapeutics Plc, Other Locations
  • Akari Therapeutics Plc, Subsidiaries
  • Akari Therapeutics Plc, Key Manufacturing facilities
  • Akari Therapeutics Plc, Key Competitors
  • Akari Therapeutics Plc, SWOT Analysis
  • Akari Therapeutics Plc, Ratios based on current share price
  • Akari Therapeutics Plc, Annual Ratios
  • Akari Therapeutics Plc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Akari Therapeutics Plc, Performance Chart
  • Akari Therapeutics Plc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3